SBIR/STTR Research Award

Neural Stem Cells From Umbilical Cord Blood

Award identifier db49a770af4321964b22dd3bfcaafafa6fbb3c7b6dc7a42822ba4f4395a22594Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$107,000

Program and phase

STTR · Phase I

Award year

2001

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
SANERON CCEL THERAPEUTICS, INC.
Proposal award date
Not reported
Contract end date
Not reported
UEI
W62DAG7PKK18
Solicitation number
Not reported
Topic code
Not reported

Research abstract

DESCRIPTION (provided by applicant): A neural stem cell is a single cell with the ability to proliferate, to self-renew over the lifetime of the organism, to generate a large number of clonally-related progeny and to replace limited numbers of neural cells in the adult brain. Recently, several research teams have reported that stem cells obtained from human bone marrow can be induced to differentiate into cells of neuronal and glial phenotype, both in vitro and in vivo. Preliminary results show that umbilical cord blood is a more abundant, readily accessible source of neural precursors than bone marrow. Through isolation, expansion and differentiation of neural stem cells from cord blood, it may be possible to provide enough neural precursors to treat, through transplantation, a variety of neurological deficits induced by neurodegenerative disease, genetic deficit, or injury. This Phase I research program proposes to isolate and characterize neural precursors from the heterogeneous population of mononuclear cells, which comprise umbilical cord blood. The optimal conditions for isolating and differentiating these cells into mature neural cells will be determined. Finally, it will be shown that the neural precursor cells can produce recovery on tests of motor and cognitive function in an animal model of brain injury. The success of directing stem cells obtained from umbilical cord blood into a neural phenotype has important implications for the therapeutic potential of stem cells in neural transplantation in humans. PROPOSED COMMERCIAL APPLICATION: NOT AVAILABLE

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Research funding history

13 SBIR/STTR records share this UEI (2001–2019). Reported award amounts total $5,316,292. Reported amounts are not federal obligations.

Phases: Phase I, Phase II

Agencies: Department of Health and Human Services

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.